StockWatch: Pfizer Under Pressure with Omicron!

A research team has found that the Pfizer vaccine has 40 times fewer antibodies available for fighting the omicron variant.

The Omicron variant has now been detected in 19 US states, and nearly 50 countries worldwide.

With the top pharmaceutical companies on red alert with this new strain, just how will stocks be affected as we head into 2022?

Timestamps:

Trade over 200 of the hottest stock CFDs with spreads starting from 0.0 pips - Open your Orbex account today!

   

START TRADING

or practice on DEMO ACCOUNT

Trading CFDs Involves high risk of loss